Official Post from Pramod Kumar: The market is predominantly driven by the increase in prevalence of AMD, lack of availability of specific treatment, and surge in geriatric population, according to P&S Intelligence.Lucentis, Eylea, and Avastin are the key drugs available globally for the management of wet AMD. Among these, Eylea is

Source: Click here